patidegib gel 4%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for patidegib gel 4%, covering 2019-07-15 to 2019-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients [Phase 2]